Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Return on Assets (2017 - 2025)

Historic Return on Assets for Adma Biologics (ADMA) over the last 14 years, with Q3 2025 value amounting to 0.37%.

  • Adma Biologics' Return on Assets rose 1900.0% to 0.37% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.37%, marking a year-over-year increase of 1900.0%. This contributed to the annual value of 0.48% for FY2024, which is 5700.0% up from last year.
  • Per Adma Biologics' latest filing, its Return on Assets stood at 0.37% for Q3 2025, which was up 1900.0% from 0.39% recorded in Q2 2025.
  • In the past 5 years, Adma Biologics' Return on Assets registered a high of 0.45% during Q4 2024, and its lowest value of 0.34% during Q1 2021.
  • Its 5-year average for Return on Assets is 0.03%, with a median of 0.12% in 2023.
  • Per our database at Business Quant, Adma Biologics' Return on Assets plummeted by -100bps in 2021 and then skyrocketed by 5300bps in 2024.
  • Quarter analysis of 5 years shows Adma Biologics' Return on Assets stood at 0.28% in 2021, then surged by 35bps to 0.18% in 2022, then soared by 54bps to 0.08% in 2023, then soared by 640bps to 0.45% in 2024, then decreased by -17bps to 0.37% in 2025.
  • Its Return on Assets was 0.37% in Q3 2025, compared to 0.39% in Q2 2025 and 0.41% in Q1 2025.